OrthoIQ raises $1.1M in debt to advance sensor-equipped orthopedic surgical tools

OrthoIQ Closes $1.1M Debt Round

OrthoIQ, a medical technology company developing smart, sensor-equipped power tools for orthopedic surgery, has raised $1.1 million in debt financing. No lead investor was disclosed for the round.

What OrthoIQ Builds

The company's flagship product, the Smart Impactor (IQ Impact), combines powered impaction with real-time force sensing. The goal is to give surgeons feedback during hip implant procedures:

• Knowing when a hip implant is fully seated.
• Detecting fractures during the procedure.

The company frames the problem in terms of downstream cost: implant loosening and intraoperative fractures are drivers of costly revision surgery.

Development Model and Timeline

OrthoIQ is running a capital-efficient virtual development model, working with ISO 13485-compliant contract firms rather than building out in-house manufacturing. According to the company:

• The device is in bench testing and early validation.
• Design freeze is targeted for 2027.
• FDA clearance is targeted for 2028.

Team

The company says its team pairs MIT-trained engineers with veteran orthopedic medtech operators and surgeons — a combination relevant to both the technical and clinical validation paths ahead.

Deal Context

The financing is structured as debt rather than equity, which is consistent with a capital-efficient, milestone-driven medtech program. Debt can extend runway through bench testing and early validation without diluting equity holders, though it typically comes with repayment obligations or milestone covenants that acquirers will want to review.

For strategics in orthopedic devices, OrthoIQ is an early-stage asset with a clearly defined regulatory path and a differentiated sensing approach to a well-understood surgical problem. The 2027 design freeze and 2028 FDA clearance targets set the diligence calendar: any acquisition or partnership conversation would likely center on bench validation data, IP around force sensing in powered impaction, and the contract-manufacturing relationships underpinning the virtual model.

Summary

• Company: OrthoIQ
• Round: Debt
• Amount: $1.1 million
• Lead investor: Not disclosed
• Product: Smart Impactor (IQ Impact) — powered impaction with real-time force sensing for orthopedic surgery
• Stage: Bench testing and early validation; design freeze targeted 2027; FDA clearance targeted 2028
• Model: Virtual development with ISO 13485-compliant contract firms
• Team: MIT-trained engineers alongside veteran orthopedic medtech operators and surgeons